Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat in Niemann-Pick Type C Disease
NCT00517153Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jan 2002
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of miglustat in Niemann-Pick disease type C (NPC), sponsored by Actelion Pharmaceuticals Ltd. Started Jan 2002; status: completed.
02
Drugs
miglustat
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on NCT00517153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517153.